Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 172
Filter
1.
Epidemiol Infect ; 147: e190, 2019 01.
Article in English | MEDLINE | ID: mdl-31364535

ABSTRACT

Infections due to Campylobacter, Escherichia coli and Salmonella pose a significant health burden in Canada, resulting in major costs to the health care system and economic impacts due to lost productivity resulting from illness. Recent literature suggests that climate may play a role in the prevalence of these pathogens along the food chain. This study used integrated surveillance data to examine associations between weather variables, serving as a proxy for climate, in agricultural areas and Campylobacter, generic E. coli and Salmonella contamination on samples of beef, poultry and swine meat products in Canada. Various temperature metrics (average, maximum and variability) were correlated with Campylobacter prevalence along the food chain. The prevalence of E. coli and Salmonella was correlated with both precipitation and temperatures metrics; however, analysis for E. coli was limited to beef and swine meats at retail settings, because prevalence in other combinations approached 100%, which obviated further analysis. Campylobacter contamination in poultry and swine at abattoir and retail settings demonstrated a seasonal trend, with increased prevalence generally from June or July through November, compared to the baseline month of December. Based on these analyses, Campylobacter is the most likely foodborne bacteria studied whose occurrence in meat products is affected by climatic changes in Canada. An exploratory analysis of data at the provincial scale, using Ontario as an example, revealed similar directional relationships between climate and bacterial prevalence.


Subject(s)
Campylobacter Infections/veterinary , Climate , Escherichia coli Infections/veterinary , Meat Products/microbiology , Salmonella Infections, Animal/epidemiology , Zoonoses/epidemiology , Animals , Campylobacter/isolation & purification , Campylobacter Infections/epidemiology , Canada/epidemiology , Escherichia coli/isolation & purification , Escherichia coli Infections/epidemiology , Food Microbiology , Prevalence , Salmonella/isolation & purification , Seasons , Zoonoses/microbiology
2.
Vet J ; 242: 48-52, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30503544

ABSTRACT

In veterinary medicine, evaluation of osteoarthritis (OA) treatment efficacy remains challenging. Measurement of activity, utilizing accelerometers, provides a surrogate measure of pain through measuring effects on activity, and the objective data collected can be used to assess the efficacy of treatments. However, little is known about how dog characteristics impact the accelerometry-measured response to treatment. The objectives of this study were to evaluate the effect of signalment and initial impairment level on accelerometer-measured changes in activity in osteoarthritic dogs after receiving a non-steroidal anti-inflammatory (NSAID). Fifty-seven client-owned dogs with OA-associated pain and mobility impairment were administered meloxicam for 2 weeks, following a 2-week baseline, and spontaneous activity was measured using an Actical accelerometer unit. Signalment factors and disease variables were recorded (age, sex, weight, impairment level, forelimb or hindlimb pain). Initial degree of impairment had a significant effect on changes in weekly (P=0.009), weekday (P=0.044) activity following NSAID treatment. Greater initial impairment was associated with larger positive changes in activity. Degree of impairment should be taken into consideration during the development of a clinical trial. Appropriate selection of candidates based on initial degree of impairment may permit a greater treatment effect, therefore increasing the power of the study.


Subject(s)
Accelerometry/veterinary , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chronic Pain/veterinary , Dog Diseases/drug therapy , Osteoarthritis, Hip/veterinary , Animals , Chronic Pain/drug therapy , Dog Diseases/physiopathology , Dogs , Female , Humans , Male , Osteoarthritis, Hip/drug therapy , Osteoarthritis, Hip/physiopathology , Pain Measurement/veterinary , Prospective Studies
3.
Pediatr Transplant ; 22(1)2018 02.
Article in English | MEDLINE | ID: mdl-29235221

ABSTRACT

Pancreatoblastoma is a rare malignant tumor in children. Surgical resection of the tumor is necessary for cure; however, due to its aggressive nature, it is often unresectable at presentation due to tumor size, local invasion, and/or metastasis. Because it is a rare tumor, there is currently no standard treatment regimen. We report a case of a 4-year-old boy who presented with metastatic pancreatoblastoma with multiple large metastases involving all four sectors of the liver. We began treatment with chemotherapy (cisplatin, 5FU, vincristine, and doxorubicin), which significantly reduced the tumor burden in both the pancreas and liver. We then performed a staged subtotal pancreatectomy, complete hepatectomy, and living donor left lateral segment liver transplant. This was followed by postoperative adjuvant chemotherapy. Our patient is alive and healthy and has now been tumor-free for 7 years with no tumor relapse.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hepatectomy , Liver Neoplasms/secondary , Liver Transplantation , Pancreatectomy , Pancreatic Neoplasms/secondary , Antineoplastic Agents/therapeutic use , Chemotherapy, Adjuvant , Child, Preschool , Disease-Free Survival , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Male , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/surgery
4.
Nano Life ; 5(2)2015 Jun 19.
Article in English | MEDLINE | ID: mdl-26884816

ABSTRACT

This paper describes the synthesis and properties of a new type of magnetic nanoparticle (MNP) for use in the hyperthermia treatment of tumors. These particles consist of 2-4 nm crystals of gamma-Fe2O3 gathered in 20-40 nm aggregates with a coating of carboxymethyl-dextran, producing a zetasize of 110-120 nm. Despite their very low saturation magnetization (1.5-6.5 emu/g), the specific absorption rate (SAR) of the nanoparticles is 22-200 W/g at applied alternating magnetic field (AMF) with strengths of 100-500 Oe at a frequency of 160 kHz.

5.
Pediatr Surg Int ; 29(3): 305-10, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23274700

ABSTRACT

PURPOSE: The objective of this study was to characterize the clinical course and outcomes of children with pancreatic pseudocysts that were initially treated non-operatively or with percutaneous drainage. METHODS: A retrospective review of children with pancreatic pseudocysts over a 12-year period was completed. Categorical variables were compared using Fischer's exact method and the Student's t test was used to compare continuous variables. Analysis was done using logistic and linear regression models. RESULTS: Thirty-six children met the criteria for pancreatic pseudocyst and 33 children were treated either non-operatively or with percutaneous drainage. Of the 22 children managed non-operatively, 17 required no additional intervention (77 %) and five required surgery. Operative procedures were: Frey procedure (3), distal pancreatectomy (1), and cystgastrostomy (1). Eight of the 11 children treated with initial percutaneous drainage required no additional treatment (72 %). The other three children underwent distal pancreatectomy. Success of non-operative management or percutaneous drainage was not dependent on size or complexity of the pseudocyst Logistic regression did not identify any patient demographic (gender, age, and weight), etiologic (trauma, non-traumatic pancreatitis) or pseudocyst characteristic (size, septations) that predicted failure of non-operative therapy. CONCLUSIONS: In children, pancreatic pseudocysts can frequently be managed without surgery regardless of size or complexity of the pseudocyst. When an intervention is needed, percutaneous drainage can be performed successfully, avoiding the need for major surgical intervention in the majority of patients.


Subject(s)
Drainage/methods , Pancreatic Pseudocyst/therapy , Adolescent , Child , Child, Preschool , Female , Gastrostomy , Humans , Infant , Logistic Models , Male , Pancreatectomy , Pancreatic Pseudocyst/etiology , Pancreaticojejunostomy , Retrospective Studies , Treatment Outcome , Young Adult
6.
J Exp Biol ; 213(Pt 7): 1069-78, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20228343

ABSTRACT

The songbird vocal organ, the syrinx, is composed of two sound generators, which are independently controlled by sets of two extrinsic and four intrinsic muscles. These muscles rank among the fastest vertebrate muscles, but the molecular and morphological foundations of this rapid physiological performance are unknown. Here we show that the four intrinsic muscles in the syrinx of male European starlings (Sturnus vulgaris) are composed of fast oxidative and superfast fibres. Dorsal and ventral tracheobronchialis muscles contain slightly more superfast fibres relative to the number of fast oxidative fibres than dorsal and ventral syringealis muscles. This morphological difference is not reflected in the highest, burst-like activation rate of the two muscle groups during song as assessed with electromyographic recordings. No difference in fibre type ratio was found between the corresponding muscles of the left and right sound generators. Airflow and electromyographic measurements during song indicate that maximal activation rate and speed of airflow regulation do not differ between the two sound sources. Whereas the potential for high-speed muscular control exists on both sides, the two sound generators are used differentially for modulation of acoustic parameters. These results show that large numbers of superfast fibre types are present in intrinsic syringeal muscles of a songbird, providing further confirmation of rapid contraction kinetics. However, syringeal muscles are composed of two fibre types which raises questions about the neuromuscular control of this heterogeneous muscle architecture.


Subject(s)
Muscle Fibers, Skeletal/physiology , Starlings/anatomy & histology , Starlings/physiology , Vocalization, Animal/physiology , Animals , Electromyography , Europe , Immunohistochemistry , Muscle Fibers, Skeletal/cytology , Respiratory Mechanics/physiology
7.
J Pediatr Surg ; 39(6): 964-8, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15185235

ABSTRACT

BACKGROUND/PURPOSE: The natural history and management of pediatric duodenal injuries are incompletely described. This study sought to review injury mechanism, surgical management, and outcomes from a collected series of pediatric duodenal injuries. METHODS: A retrospective chart review was conducted for a 10-year period of all children less than 18 years old treated for duodenal injuries at 2 pediatric trauma centers. RESULTS: Forty-two children were treated for duodenal injuries. There were 33 blunt and 9 penetrating injuries. Injuries were classified using the Organ Injury Scale for the Duodenum. Twenty-four patients underwent operative management by primary repair (18), duodenal resection and gastrojejunostomy (4), or pyloric exclusion (2). Duodenal hematomas were treated nonoperatively in 94% of cases. The average ISS for operative versus nonoperative cases was 23 and 10, respectively. Delay in diagnosis or operative intervention (>24 hours) was associated with increased complication rate (43% v 29%) and hospitalization (32 v 20 days). Nine children requiring surgery experienced delays and were most highly associated with foreign body, child abuse, and bicycle injuries. There were no deaths caused by duodenal injuries. CONCLUSIONS: Duodenal injuries in children were predominantly blunt and had a low mortality rate. When surgery was required, primary repair was usually feasible.


Subject(s)
Case Management , Duodenum/injuries , Accidents/statistics & numerical data , Adolescent , Child , Child Abuse/statistics & numerical data , Child, Preschool , Duodenum/surgery , Female , Foreign Bodies/epidemiology , Foreign Bodies/therapy , Gastrointestinal Hemorrhage/therapy , Hematoma/therapy , Hospitals, Pediatric/statistics & numerical data , Humans , Infant , Lacerations/epidemiology , Lacerations/therapy , Length of Stay/statistics & numerical data , Male , Multiple Trauma/epidemiology , Philadelphia/epidemiology , Postoperative Complications , Retrospective Studies , Trauma Centers/statistics & numerical data , Trauma Severity Indices , Utah/epidemiology , Wounds, Nonpenetrating/epidemiology , Wounds, Nonpenetrating/therapy , Wounds, Penetrating/epidemiology , Wounds, Penetrating/therapy
8.
Bone Marrow Transplant ; 31(8): 643-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12692603

ABSTRACT

The pharmacokinetics of two etoposide (E) formulations were evaluated in patients with refractory hematologic malignancies receiving high-dose conditioning with autologous stem cell transplantation. Patients were randomized to either E at 800 mg/m(2) (containing polysorbate 80 and polyethylene glycol) or etoposide phosphate (EP) at 910 mg/m(2) on days -7 and -5, prior to melphalan, 80 mg/m(2) on day -5. On day -3, EP was repeated. Plasma E was analyzed after each formulation on days -7 and -5 to compare intrapatient pharmacokinetics. In total, 10 patients were treated: four each with multiple myeloma or Hodgkin's disease and two with non-Hodgkin's lymphoma. Mucositis was the major toxicity with seven patients. EP first produced grade 3 mucositis. There was no procedure-related mortality and eight patients remained alive 1 year post-transplant. Cumulative etoposide exposure (AUC) was slightly greater with EP (P=0.056). Conversely, the volume of distribution was slightly, 33%, larger (P=0.052) and clearance was increased with the E infusion (P=0.14). As none of the differences reached statistical significance, both E formulations appear to be pharmacokinetically equivalent in the high-dose transplant setting. The combination of high-dose EP with melphalan is an active preparative regimen prior to ABMT for hematologic malignancies.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Etoposide/analogs & derivatives , Etoposide/pharmacokinetics , Lymphoma/therapy , Organophosphorus Compounds/pharmacokinetics , Stem Cell Transplantation , Adult , Aged , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics , Area Under Curve , Chromatography, High Pressure Liquid , Etoposide/therapeutic use , Hodgkin Disease/drug therapy , Hodgkin Disease/therapy , Humans , Life Expectancy , Lymphoma/drug therapy , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin/therapy , Melphalan/pharmacokinetics , Middle Aged , Multiple Myeloma/drug therapy , Multiple Myeloma/therapy , Organophosphorus Compounds/therapeutic use , Time Factors , Transplantation, Autologous
10.
Can J Public Health ; 92(5): 361-5, 2001.
Article in English | MEDLINE | ID: mdl-11702490

ABSTRACT

Cases of giardiasis in Ontario were described using notifiable disease data from the Ontario Ministry of Health for the years 1990-1998 inclusive. The mean annual age- and sex-adjusted incidence rate was 25.77 cases per 100,000 population for the 25,289 cases reported. Children under five years of age had the highest incidence of disease. Males had a higher mean annual incidence in all age groups. Four deaths occurred among cases. The most frequently reported symptoms were loose stools or watery diarrhea (50.1%). A seasonal pattern was noted, peaking in late summer and early autumn. The most frequently reported probable risk settings were the home (40.1%) and travel (39.1%). The study findings suggest that a high proportion of cases occur in urban areas and spatial analysis showed the highest incidence around Lake Huron and Georgian Bay. Unfiltered water and person-to-person contact are believed to be important sources of infection.


Subject(s)
Giardiasis , Population Surveillance , Adult , Age Distribution , Aged , Child , Child, Preschool , Female , Giardiasis/diagnosis , Giardiasis/epidemiology , Giardiasis/transmission , Humans , Incidence , Male , Middle Aged , Ontario/epidemiology , Risk Factors , Seasons , Sex Distribution
11.
Dev Neurosci ; 23(3): 234-47, 2001.
Article in English | MEDLINE | ID: mdl-11598326

ABSTRACT

Cerebral hypoxia/ischemia of the newborn has a frequency of 4/1,000 births and remains a major cause of cerebral palsy, epilepsy, and mental retardation. Despite progress in understanding the pathogenesis of hypoxic-ischemic injury, the data are incomplete regarding the mechanisms leading to permanent brain injury. Here we tested the hypothesis that cerebral hypoxia/ischemia damages stem/progenitor cells in the subventricular zone (SVZ), resulting in a permanent depletion of oligodendrocytes. We used a widely accepted rat model and examined animals at recovery intervals ranging from 4 h to 3 weeks. Within hours after the hypoxic-ischemic insult 20% of the total cells were deleted from the SVZ. The residual damaged cells appeared necrotic. During 48 h of recovery deaths accumulated; however, these later deaths were predominantly apoptotic. Many apoptotic SVZ cells stained with a marker for immature oligodendrocytes. At 3 weeks survival, the SVZ was smaller and markedly less cellular, and it contained less than 1/4 the normal complement of neural stem cells. The corresponding subcortical white matter was dysmyelinated, relatively devoid of oligodendrocytes and enriched in astrocytes. We conclude that neural stem cells and oligodendrocyte progenitors in the SVZ are vulnerable to hypoxia/ischemia. Consequently, the developmental production of oligodendrocytes is compromised and regeneration of damaged white matter oligodendrocytes does not occur resulting in failed regeneration of CNS myelin in periventricular loci. The resulting dysgenesis of the brain that occurs subsequent to perinatal hypoxic/ischemic injury may contribute to the cognitive and motor dysfunction that results from asphyxia of the newborn.


Subject(s)
Cerebral Ventricles/embryology , Hypoxia-Ischemia, Brain/pathology , Neurons/pathology , Oligodendroglia/pathology , Stem Cells/pathology , Animals , Apoptosis , Cerebral Palsy/pathology , Cerebral Ventricles/pathology , Female , Pregnancy , Rats , Rats, Wistar , Stroke/pathology
12.
Cancer Lett ; 171(1): 47-56, 2001 Sep 28.
Article in English | MEDLINE | ID: mdl-11485827

ABSTRACT

tetra-O-methylnordihydroguaiaretic acid is a derivative of a naturally-occurring lignan, nordihydroguaiaretic acid, that has previously been shown to inhibit various cancer types in vitro and in vivo. Additionally, nordihydroguaiaretic acid has been shown to have nephrotoxic effects in the rat. Here we show that tetra-O-methylnordihydroguaiaretic acid inhibits the growth of a number of tumor cell lines in vitro by inducing apoptosis in a non-schedule-dependent manner. Further, this compound inhibits the synthesis of DNA by melanoma cells and causes cell cycle arrest in G0/G1 and G2/M phases of the cell cycle. tetra-O-Methylnordihydroguaiaretic acid also inhibits the growth of both murine and human melanomas and human colon cancer in vivo without apparent hepatic or renal toxicity.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents, Phytogenic/therapeutic use , Colonic Neoplasms/drug therapy , Masoprocol/therapeutic use , Melanoma, Experimental/drug therapy , Adenocarcinoma/pathology , Animals , Antineoplastic Agents, Phytogenic/toxicity , Apoptosis/drug effects , Breast Neoplasms/pathology , Cell Cycle/drug effects , Colonic Neoplasms/pathology , DNA Replication/drug effects , Female , Intracellular Membranes/drug effects , Kidney/drug effects , Liver/drug effects , Lung Neoplasms/pathology , Male , Masoprocol/analogs & derivatives , Masoprocol/toxicity , Melanoma/pathology , Membrane Potentials/drug effects , Mice , Mice, Inbred C57BL , Mice, SCID , Mitochondria/drug effects , Neoplasm Transplantation , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/transplantation , Xenograft Model Antitumor Assays
13.
J Pediatr Surg ; 36(8): 1146-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11479844

ABSTRACT

BACKGROUND: Congenital atresia of the small and large intestine is thought to evolve from in utero mesenteric vascular occlusion of the corresponding intestinal segment. Because spontaneous thrombosis recently has been described in association with inherited thrombophilia, the authors wondered if inherited thrombophilia also might be found in babies with intestinal atresia. METHODS: Genetic analysis was done on 28 children treated for congenital intestinal atresia. DNA was analyzed for point mutations to detect the 2 most common types of inherited thrombophilia, the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A mutation in the prothrombin gene. In addition, other genetic risk factors for thrombosis were analyzed including the C677T mutation in the methylenetetrahydrofolate reductase gene (MTHFR) and 2 polymorphisms of the factor VII gene (the R353Q and the hypervariable region 4 polymorphisms). RESULTS: The factor V Leiden mutation was present in 5 of 28 (18%) children treated for congenital intestinal atresia. This is increased significantly when compared with the reported carrier frequency of 3% to 7% in the general population and a reported carrier rate of 4.2% in the local population (P <.005). The R353Q polymorphism of the factor VII gene, specifically the RR genotype, was noted in 85% of patients with atresia with an expected frequency of 64% (P <.008). There were no significant associations noted between mutations in the prothrombin gene, the MTHFR gene, or the hypervariable region of the factor VII gene. CONCLUSIONS: The factor V Leiden mutation and the RR subtype of the R353Q polymorphism of the factor VII gene are seen at an increased frequency in children with congenital intestinal atresia. This suggests that inherited thrombophilia may play a role in the etiology of these in utero mesenteric thrombotic events.


Subject(s)
Factor V/genetics , Genetic Predisposition to Disease/epidemiology , Intestinal Atresia/epidemiology , Intestinal Atresia/genetics , Intestine, Large/abnormalities , Intestine, Small/abnormalities , Thrombophilia/epidemiology , Thrombophilia/genetics , Cohort Studies , Comorbidity , Female , Humans , Infant , Infant, Newborn , Intestinal Atresia/diagnosis , Male , Pregnancy , Prevalence , Reference Values , Risk Factors , Thrombosis/epidemiology , Thrombosis/genetics
14.
J Chromatogr B Biomed Sci Appl ; 754(1): 85-90, 2001 Apr 15.
Article in English | MEDLINE | ID: mdl-11318430

ABSTRACT

Nordihydroguaiaretic acid (NDGA) has been shown to inhibit both 5-lipoxygenase and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model. Despite these findings, there have been no reports on the pharmacokinetics of NDGA. A reverse-phase high-performance liquid chromatography (HPLC) method was developed to detect NDGA in mouse plasma. The limit of detection of this method was 0.5 microg/ml. Administration of NDGA (50 mg/kg, i.v.) to mice resulted in a peak plasma concentration of 14.7 microg/ml. The terminal half-life of NDGA was 135.0 min with a clearance of 201.9 ml/min x kg.


Subject(s)
Masoprocol/pharmacokinetics , Animals , Chromatography, High Pressure Liquid , Injections, Intravenous , Masoprocol/administration & dosage , Masoprocol/standards , Mice , Molecular Structure , Reproducibility of Results
15.
Am J Addict ; 10(s1): s51-s59, 2001.
Article in English | MEDLINE | ID: mdl-11268821

ABSTRACT

Empirical support is presented for the Community Reinforcement Approach (CRA), a broad-spectrum cognitive-behavioral treatment for substance use disorders. At the core of CRA is the belief that an individual's environment can play a powerful role in encouraging or discouraging drinking and drug use. Consequently, it attempts to rearrange contingencies so that sober behavior is more rewarding than substance-abusing behavior. Originally tested in the early 1970s with a small sample of alcohol-dependent inpatients, it has repeatedly proven to be successful over the years with larger, diverse populations. Empirical backing is also presented for a new variant of CRA that works through family members to engage treatment-resistant individuals into substance abuse treatment.


Subject(s)
Cognitive Behavioral Therapy/methods , Community Mental Health Services/organization & administration , Reinforcement, Psychology , Substance-Related Disorders/rehabilitation , Ambulatory Care , Family Therapy , Humans , Illicit Drugs
16.
J Pediatr Surg ; 35(11): 1586-90, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11083429

ABSTRACT

PURPOSE: In difficult cases of congenital adrenal hyperplasia (CAH), often the child may have normal cortisol levels and elevated androgen levels, or normal androgen levels and elevated cortisol levels, but not normal levels of both. Because bilateral adrenalectomy removes the source of the abnormal androgen production, the authors felt that in some cases it might be more efficacious than conventional medical therapy. METHODS: Three children with CAH and suboptimal response to medical management underwent bilateral laparoscopic adrenalectomy. Parents were counseled extensively regarding the experimental nature of this treatment and the potential long-term complications. RESULTS: All children recovered quickly after a mean hospital stay of 1.8 days. Pathologic examination of the removed adrenal glands showed persistent cortical hyperplasia. Follow-up at 6 months indicated marked reduction in abnormal androgen production, which allowed lowering of the steroid dosing to physiologic levels. CONCLUSION: In children with CAH refractory to medical management, bilateral laparoscopic adrenalectomy can be performed safely with almost trivial morbidity. Although early results are very encouraging, the anticipated long-term beneficial effects on growth, short stature, and adult infertility will require years to assess.


Subject(s)
Adrenal Hyperplasia, Congenital/surgery , Adrenalectomy/methods , Laparoscopy/methods , Adrenal Hyperplasia, Congenital/diagnosis , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Male , Minimally Invasive Surgical Procedures/methods , Sensitivity and Specificity , Severity of Illness Index , Treatment Outcome
17.
J Subst Abuse Treat ; 19(3): 215-22, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11027890

ABSTRACT

Runaway/homeless shelters document high levels of substance abuse among runaway youth, at least double that of school youth. These youth present a constellation of problems and research suggests that this population may be unique in the range and intensity of associated problems. Most studies to date have collected self-report data on these youth; virtually no research has examined treatment effectiveness with the population. Given the void of treatment outcome research with these youths, there is need for identifying potent interventions. Given that issues of engagement and retention must assume prominence in the development of new treatments, this article presents a family-based treatment engagement strategy successfully employed with a sample of substance-abusing youth staying in a southwestern shelter. Youth and primary caretakers are engaged separately by the therapist utilizing motivating factors appropriate to context of the families' lives and to the developmental position of the client.


Subject(s)
Family Therapy , Homeless Youth/psychology , Patient Acceptance of Health Care/psychology , Runaway Behavior , Substance-Related Disorders/rehabilitation , Adolescent , Combined Modality Therapy , Female , Humans , Male , Motivation , Patient Care Team , Substance-Related Disorders/psychology , Treatment Outcome
18.
Semin Pediatr Surg ; 9(3): 146-55, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10949425

ABSTRACT

There is a remarkable diversity of conditions encompassed by benign liver masses in infants and toddlers. The most common benign hepatic tumor in this age group is infantile hepatic hemangioendothelioma. Other commonly seen benign tumors are mesenchymal hamartoma and focal nodular hyperplasia. Hepatic adenoma is almost exclusively a disease of older children; primary hepatic teratoma is exceedingly rare. There are several distinguishing characteristics of these benign tumors on radiographic evaluation; however, imaging techniques such as ultrasound scan, computed tomography, and angiography are not always reliable in differentiating benign from malignant tumors. The differential diagnosis of benign hepatic tumors includes nonneoplastic cystic masses including biliary and simple hepatic cysts, hematoma, parasitic cysts, and pyogenic and amebic liver abscess. Choledochal cyst presents with a classic triad of abdominal pain, cholestatic jaundice, and a palpable abdominal mass. They are classified anatomically into 5 subtypes with the most popular types being type I and type IV. Treatment is with complete cyst excision with hepaticojejunostomy reconstruction.


Subject(s)
Choledochal Cyst , Liver Neoplasms , Choledochal Cyst/diagnosis , Choledochal Cyst/surgery , Cysts/pathology , Cysts/surgery , Focal Nodular Hyperplasia/pathology , Focal Nodular Hyperplasia/surgery , Hamartoma/diagnosis , Hamartoma/surgery , Hemangioendothelioma/diagnosis , Hemangioendothelioma/pathology , Hemangioendothelioma/therapy , Humans , Infant , Infant, Newborn , Liver Diseases/diagnosis , Liver Diseases/surgery , Liver Neoplasms/diagnosis , Liver Neoplasms/pathology , Liver Neoplasms/therapy , Liver Transplantation
19.
J Morphol ; 244(2): 109-25, 2000 May.
Article in English | MEDLINE | ID: mdl-10761049

ABSTRACT

Twenty-three species within the avian family Alcidae are capable of wing-propelled flight in the air and underwater. Alcids have been viewed as Northern Hemisphere parallels to penguins, and have often been studied to see if their underwater flight comes at a cost, compromising their aerial flying ability. We examined the anatomy and histochemistry of select wing muscles (Mm. pectoralis, supracoracoideus, latissimus dorsi caudalis, coracobrachialis caudalis, triceps scapularis, and scapulohumeralis caudalis) from Atlantic puffins (Fratercula arctica) to assess if the muscle fiber types reveal the existence of a compromise associated with "dual-medium" flight. Pectoralis was found to be proportional in size with that of nondiving species, although the supracoracoideus was proportionally larger in puffins. Muscle fiber types were largely aerobic in both muscles, with two distinct fast-twitch types demonstrable: a smaller, aerobic, moderately glycolytic population (FOg), and a larger, moderately aerobic, glycolytic population (FoG). The presence of these two fiber types in the primary flight muscles of puffins suggests that aerial and underwater flight necessitate a largely aerobic fiber complement. We suggest that alcids do not represent an adaptive compromise, but a stable adaptation for wing-propelled locomotion both in the air and underwater.


Subject(s)
Birds/anatomy & histology , Muscle, Skeletal/anatomy & histology , Wings, Animal/anatomy & histology , Animals , Diving , Flight, Animal , Histocytochemistry
20.
Nat Cell Biol ; 1(5): 280-7, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10559940

ABSTRACT

The small GTPase ADP-ribosylation factor (ARF) regulates the structure and function of the Golgi complex through mechanisms that are understood only in part, and which include an ability to control the assembly of coat complexes and phospholipase D (PLD). Here we describe a new property of ARF, the ability to recruit phosphatidylinositol-4-OH kinase-beta and a still unidentified phosphatidylinositol-4-phosphate-5-OH kinase to the Golgi complex, resulting in a potent stimulation of synthesis of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate; this ability is independent of its activities on coat proteins and PLD. Phosphatidylinositol-4-OH kinase-beta is required for the structural integrity of the Golgi complex: transfection of a dominant-negative mutant of the kinase markedly alters the organization of the organelle.


Subject(s)
1-Phosphatidylinositol 4-Kinase/metabolism , ADP-Ribosylation Factors/metabolism , Golgi Apparatus/metabolism , Membrane Lipids/biosynthesis , Phosphatidylinositol 4,5-Diphosphate/biosynthesis , Animals , Brain/metabolism , Cattle , Cell Line , Cytosol/metabolism , Intracellular Membranes/metabolism , Liver/metabolism , Phospholipase D/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL